CV Sciences, Inc.
(OOTC : CANV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading CANV News...
...
Consumer Services » Other Consumer Services
symbolcompany%chnglast%shortavg$volume
PCLNPriceline Group Inc
-11.37%1232.142.8%$854.21m
CTRPCtrip.com International Ltd Sponsored ADR
-2.58%39.608.6%$292.41m
EBAYeBay Inc.
-6.92%23.131.7%$220.96m
EXPEExpedia, Inc.
-7.41%101.769.9%$188.35m
HRBH&R Block, Inc.
-2.71%22.2310.2%$114.68m
TRIPTripAdvisor, Inc.
-6.23%61.8710.8%$113.68m
EDUNew Oriental Education & Technology Group, Inc. Sponsored ADR
0.64%41.052.7%$75.25m
SERVServiceMaster Global Holdings Inc
-2.32%37.494.2%$45.66m
XRSTAL Education Group Unsponsored ADR Class A
1.04%57.599.5%$38.78m
BIDSotheby's Class A
-9.15%27.1217.2%$32.91m
SCIService Corporation International
-3.89%26.174.2%$26.59m
HMHCHoughton Mifflin Harcourt Company
-2.80%15.614.5%$19.43m
DVDeVry Education Group Inc.
-5.22%17.5215.8%$17.70m
WTWWeight Watchers International, Inc.
-8.52%12.3526.6%$14.02m
PLNTPlanet Fitness Inc Class A
-3.00%18.4311.8%$13.91m

Company Profile

CV Sciences, Inc. is a life science company, which develops, produces, markets and sells raw materials and end consumer products containing the hemp plant extract, Cannabidiol (CBD) to the nutraceutical, beauty care, pet care, specialty beverage and functional food sectors. The company operates its business through two segments: Specialty Pharmaceuticals and Consumer Products. The Specialty Pharmaceuticals segment is focused on developing and commercializing novel therapeutics utilizing synthetic Cannabidiol. The Consumer Products segment engages in the manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The company was founded by H. J. Cole on December 9, 2010 and is headquartered in Las Vegas, NV.